You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Leiomyosarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Recruiting
  • Locally Advanced Leiomyosarcoma
  • +5 more
  • New York, New York
    Columbia University/Herbert Irving Cancer Center
Jan 4, 2023

Leiomyosarcoma Trial in Santa Monica (Trabectedin)

Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
    Sant P Chawla
Oct 13, 2022

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +8 more
  • (no location specified)
Jul 6, 2022

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Retroperitoneal Sarcoma AJCC v8 Trial in Columbus

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +6 more
  • Niraparib Tosylate Monohydrate
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 25, 2022

Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma, Uterine Corpus Leiomyosarcoma Trial in Boston (Ipilimumab, Laboratory

Active, not recruiting
Has Results
  • Metastatic Leiomyosarcoma
  • +2 more
  • Ipilimumab
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Advanced Leiomyosarcoma Trial in Boston (Lurbinectedin,

Recruiting
  • Advanced Soft-tissue Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)

Recruiting
  • Leiomyosarcoma
  • Liposarcoma
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Nov 23, 2022

Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

Active, not recruiting
  • Leiomyosarcoma
  • +3 more
  • Taipei, Taiwan
  • +1 more
Dec 27, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Leiomyosarcoma of Ovary, Soft Tissue Sarcoma Trial in Italy (Trabectedin, Gemcitabine, No Intervention: Observational Cohort)

Active, not recruiting
  • Leiomyosarcoma of Ovary
  • Soft Tissue Sarcoma
  • Bologna, BO, Italy
  • +12 more
Oct 29, 2021

Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2022

Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )

Active, not recruiting
  • Alveolar Soft Part Sarcoma
  • +3 more
  • Phoenix, Arizona
  • +22 more
Nov 1, 2022

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting
  • Metastatic Leiomyosarcoma
  • +5 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Feb 2, 2023

Leiomyosarcoma Metastatic Trial in Korea, Republic of (Avelumab and Gemcitabine)

Unknown status
  • Leiomyosarcoma Metastatic
  • Avelumab and Gemcitabine
  • Busan, Korea, Republic of
  • +5 more
Feb 2, 2021

Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United States (Computed

Active, not recruiting
  • Stage III Uterine Corpus Leiomyosarcoma AJCC v8
  • Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
  • Computed Tomography
  • +4 more
  • Phoenix, Arizona
  • +14 more
Aug 23, 2022

Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

Not yet recruiting
  • Metastatic Extraskeletal Myxoid Chondrosarcoma
  • +3 more
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Liposarcoma, Leiomyosarcoma Trial in Italy (Trabectedin)

Completed
  • Liposarcoma
  • Leiomyosarcoma
  • Bari, BA, Italy
  • +20 more
Oct 29, 2021

Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

Withdrawn
  • Soft Tissue Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Nov 30, 2021

Nasopharyngeal Carcinoma, EBV-Related Gastric Carcinoma, EBV-Related Leiomyosarcoma Trial in Worldwide (Nanatinostat,

Recruiting
  • Nasopharyngeal Carcinoma
  • +4 more
  • Lynwood, California
  • +20 more
Jul 27, 2022

Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma Trial in Houston, Chuo-Ku (LY3435151, Pembrolizumab)

Terminated
Has Results
  • Solid Tumor
  • +8 more
  • Houston, Texas
  • +1 more
Aug 4, 2021

Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

Withdrawn
  • Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Jul 26, 2021

Leiomyosarcoma Trial in Beijing (Temozolomide for injection combined with epirubicin)

Recruiting
  • Leiomyosarcoma
  • Temozolomide for injection combined with epirubicin
  • Beijing, Beijing, China
    Cancer Hospital of Chinese Academy of Medical Sciences
Jan 11, 2022

Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

Recruiting
  • Sarcoma,Soft Tissue
  • Tenerife, Canarias, Spain
  • +10 more
Oct 27, 2023

Soft Tissue Sarcoma Trial (ADI PEG20, Placebo)

Not yet recruiting
  • Soft Tissue Sarcoma
  • ADI PEG20
  • Placebo
  • (no location specified)
Jan 31, 2023